Alu elements contribute considerably to gene regulation and genome evolution in primates. The generation of new exons from Alu elements has been found in various human genes, and the regulatory function of the Alu exon has been investigated in many studies. However, the functionalization of Alu elements in protein coding regions remains unknown. Here, we reported that an Alu-J element exonized in the glycoprotein hormone alpha (GPHA) gene and encoded an additional N-terminal peptide (Alu-J encoding peptide) of the mature GPHA peptide, leading to a splicing variant of Alu-GPHA in anthropoid primates $35 Ma. Interestingly, adaptive evolution of the Alu-J exon occurred in the human and ape lineages during anthropoid evolution. The Alu-J encoding peptide is found to be a new biomarker in human early pregnancy and prolongs the serum half-life of human chorionic gonadotropin (HCG) circulation. Moreover, Alu-J encoding peptide enhances the bioactivity of HCG protein, both in vivo and in vitro. Our study reveals the first example of an Alu element functioning as the encoding peptide to increase the whole protein stability and provides insight into the potential multi-functionalization of the Alu exon in the protein coding regions. Furthermore, with the chorionic gonadotropin linking with hemochorial placentation, the exonization and functionalization of the Alu-J exon in GPHA gene represent a novel mechanism to the evolution of hemochorial placentation in primates.
Introduction
Approximately half of the human genome is derived from transposable elements, and primate-specific Alu sequences, $300 base-pair long each, are the dominant short interspersed nuclear elements (SINEs) in primate genomes (Cordaux and Batzer 2009; Hasler and Strub 2006) . Originating $60 Ma, Alu elements frequently form new exons in primate genomes, and their migration in the genome allows the shaping of primate evolution (Attig et al. 2016; Kazazian 2004; Lin et al. 2016 ). In particular, in the human genome, there are approximately one million copies of the Alu element, accounting for $10% of our genome, and $4% of human genes contain the Alu sequence in the coding regions, indicating exonization events (Lev-Maor et al. 2007; Nekrutenko and Li 2001) . On the basis of the human genome, the Alu elements can be classified into at least two major subfamilies, Alu-S and Alu-J (Jurka and Milosavljevic 1991) . The Alu-S subfamily consists of at least five distinct subfamilies referred to as Alu-Sx, Alu-Sq, Alu-Sp, Alu-Sc, and Alu-Sb by sequence analysis (Jurka and Milosavljevic 1991) . The Alu-J subfamily is taken as one of the oldest Alu elements and shows activity during early primate divergence, and the Alu-S subfamily shows highest amplification approximately at the first splitting point of anthropoids $40 Ma (Jurka and Milosavljevic 1991; Krull et al. 2005; Quentin 1988 ). Nearly all Alu subfamilies have been found to be exonized into the untranslated region (UTR) or the open reading frame (ORF) of the human genes (Sorek et al. 2002) . Newly created 5 0 UTR/3 0 UTR Alu exon has been reported to have various regulatory functions, for example, increasing mRNA transcription (Vansant and Reynolds 1995) , silencing gene expression (Chen et al. 2008 ) and altering mRNA translational efficiency (Shen et al. 2011) . In contrast, Alu-derived internal exons are considered to be usually alternatively spliced, thus allowing the original isoform to coexist with the newly formed variant and the possibility to evolve new functions (Lev-Maor et al. 2003) .
Human glycoprotein hormones-chorionic gonadotropin (CG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH)-are heterodimers formed between a common alpha subunit-glycoprotein hormone alpha (GPHA also named CGA or LHA, or FSHA or TSHA) and four different beta subunits-CGB, LHB, FSHB, and TSHB, respectively (Fournier et al. 2015; Pierce and Parsons 1981) . Both GPHA and beta subunits of glycoprotein hormones are cystine-knot containing proteins, a feature conserved in the basal metazoans, and they play an important role in mammalian growth and development (Roch and Sherwood 2014) . CG and LH consist of the GPHA subunit with CGB and LHB, respectively, and both of them activate LH receptor (LHR) to regulate ovarian, testicular, and placental functions (Fournier et al. 2015) . In contrast, FSH and TSH consist of the GPHA subunit with FSHB and TSHB, respectively. FSH acts on FSH receptor (FSHR) to regulate gonadal functions whereas TSH acts on TSH receptor (TSHR) to regulate thyroid functions (Davies et al. 2002; Simoni et al. 1997) . All three glycoprotein hormone receptors (LHR, FSHR, and TSHR) are classical G-protein coupled receptors (GPCRs) with a large ectodomain containing leucine-rich repeats (Fan and Hendrickson 2005) . The binding of the glycoprotein hormone heterodimers to the ectodomain of their cognate receptors stimulates Gs (The Gs alpha subunit-Gs protein is a heterotrimeric G protein subunit that activates the cAMP-dependent pathway by activating adenylyl cyclase) signaling in target cells to increase cAMP biosynthesis (Fan and Hendrickson 2005) .
CG produced by the trophoblast is an important hormone for early pregnancy (Cole 2010; Hearn et al. 1991) . After embryo implantation, CG promotes the maintenance of the corpus luteum during the beginning of pregnancy, and CG acts on extravillous invasive villous cytotrophoblast (Vctb) cells to initiate and control invasion during the implantation stage of pregnancy and the establishment of hemochorial placentation (Carter 2007; Cole 2009b; Licht et al. 2007 ). During pregnancy, placental implantation and invasion characteristics in primates are variable and related to CG's function-invasion activity and half-life characteristics (Cole 2009a (Cole , 2009b (Cole , 2010 . According to evolution of primate hemochorial placentation, human hemochorial placentation evolved from the more primitive hemochorial placentation seen in advanced and early simian primates (Luckett 1974) . So, several evolutionary events occurred in the CG beta subunit-CGB gene during primate evolution provide good explanation to the evolution of hemochorial placentation in primates (Cole 2009a (Cole , 2009b Maston and Ruvolo 2002) . However, evolution of CG alpha subunit-GPHA gene during primate evolution has not been found to be linked with the evolution of hemochorial placentation in primates.
The exonization of the Alu element is a major mechanism for de novo exon creation in primate genomes (Lev-Maor et al. 2003) . Although the regulatory function of exonized Alu elements has been investigated by many studies (Chen et al. 2008; Shen et al. 2011; Vansant and Reynolds 1995) , the functionalization of Alu elements in protein coding regions remains unknown. Here, we identified an Alu-J element exonized and functionalized in the protein coding region of GPHA gene, leading to a more effective CG isoform (Alu-CG/ Alu-HCG) during anthropoid evolution. To the best of our knowledge, Alu-GHPA provides the first example of the functionalization of the Alu element in protein coding regions. Furthermore, with the CG linking with hemochorial placentation, the exonization and functionalization of an Alu-J element in the protein coding region of CG alpha subunit-GPHA gene also represent a novel mechanism to the evolution of hemochorial placentation in primates.
Results
Exonization of an Alu-J Element Led to an Alu-J Encoding Peptide and a Splicing Variant of GPHA (Alu-GPHA) in Anthropoids GPHA is a conserved polypeptide hormone in vertebrates and is highly conserved in humans and mice (Park et al. 2005 ; fig. 1A ). On the basis of the analysis of the genome sequence of the human GPHA gene, there are two splicing variants-normal GPHA and Alu-GPHA which include an additional exon originating from an Alu element that belongs to the Alu-J subfamily (Jurka and Milosavljevic 1991; fig. 1A and B and supplementary fig. S1 , Supplementary Material online). The Alu-J exon contributes 93 NTs (nucleotides) to create a new exon (Alu-J exon) encoding 31 residues (Alu-J encoding peptide) only between exon 1 which encodes a signal peptide of GPHA, and exon 2, which encodes the mature GPHA peptide in the GPHA gene and shows relatively high conservation in both NT (supplementary fig. S1 , Supplementary Material online) and protein sequence ( fig.  1B) , according to the sequences from the eleven anthropoid primates which have their whole genomes sequenced ( fig. 1B  and D) .
Because Alu elements are conserved and specific to primates, we traced the origination of the Alu-J exon in primate genomes. As shown in figure 1C and supplementary figure S2, Supplementary Material online, this Alu-J exon exists in all anthropoid primates but is absent in prosimians, for example, Tarsius syrichta and Otolemur garnettii. Furthermore, with the genomic locus sequence alignment of anthropoid primates and two prosimians, T. syrichta and O. garnettii, we found that two head-to-tail Alu elements (one belongs to the Alu-Sq subfamily and the other belongs to the Alu-J subfamily, Jurka and Milosavljevic 1991, which generate the Alu-J exon) are only reversely inserted in TAG-TTT, which is an identical genomic sequence in squirrel monkey (Saimiri boliviensis) and philippine tarsier (T. syrichta; fig. 1C and supple mentary fig. S2 , Supplementary Material online). The alignment of genomic sequence flanking the Alu insertion sites between anthropoid primates and prosimians also show large conservation (supplementary fig. S2 , Supplementary Material online).
Sequence motifs from Alu elements resemble 5 0 and 3 0 potential splice sites and random mutations can turn these motifs into functional splice sites (Athanasiadis et al. 2004; Lev-Maor et al. 2003) . The 93 NTs flanking with the classic GT-AG splice site from the Alu-J element generate the Alu-J exon in squirrel monkey ( fig. 1C) . Interestingly, the alignment of the Alu-J exon and other Alu-J elements in various primate species shows that the AG splice site is highly conserved in the Alu-J subfamily for a natural exon-intron splice site; and the PolyT and short repetitive sequence were shown underline and italic. The Alu-J exon is shown in red, and the GT-AG exon-intron splicing sites are inside in box. The alignment of genomic sequence flanking the Alu insertion sites in squirrel monkey (Saimiri-Saimiri boliviensis) and philippine tarsier (Tarsius-Tarsius syrichta) (lower). (D) Phylogenetic tree of the primate species and Alu-J element insertion in anthropoids. Phylogenetic relationships among different primate species are based on previous studies (Harada et al. 1995; Page et al. 1999 ) with the divergence times Chen et al. . doi:10.1093/molbev/msx252 MBE alignment also shows that GC, the ancestor of the GT splice site in the Alu-J exon, is also highly conserved in the Alu-J subfamily in various primate species ( fig. 1E and supplemen tary fig. S3A , Supplementary Material online). So, sequence alignment suggests that GC to GT substitution drives the exonization of the Alu-J element after insertion in anthropoid primates ( fig. 1E and supplementary fig. S3A , Supplementary Material online). The Alu-J subfamily is one of the oldest Alu elements and shows activity during early primate divergence (Jurka and Milosavljevic 1991; Krull et al. 2005 fig. 1D) , and for the Alu-J encoding peptide, C-terminal amino acid substitution occurred at a relatively higher frequency in various primates, compared with its N-terminus ( fig. 1B) . To assess whether the Alu-J encoding peptide undergoes adaptive evolution after exonization in anthropoid primates, we used a branch-site model to test for positive selection in these primate lineages ( fig. 2A ). As shown in figure 2A , the results showed that the common ancestor of the human and ape lineages has a large nonsynonymous (dN)/synonymous (dS) substitution rate ratio (branch-site dN/dS of x ) 1) that is highly significant (likelihood ratio tests-LRT, P < 0.01; fig. 2B ), whereas all other lineages do not exhibit this ratio, suggesting that positive Darwinian selection occurred specifically in the human and ape lineages ( fig. 2A ). Moreover, one K residue in the 22nd position in the Cterminus of the Alu-J encoding peptide was identified to be under positive selection ( fig. 2B ). We also used the aBSREL method (http://datamonkey.org) to test for positive selection in these primate lineages (Smith et al. 2015) , and the results still showed x ) 1 in the common ancestor of the human and ape lineages, although P value did not show significant (supplementary fig. S3C , Supplementary Material online). Taken together, our results imply adaptive evolution of the Alu-J encoding peptide of Alu-GPHA in the human and ape lineages and suggest a gain of function in the Alu-J encoding peptide and Alu-GPHA.
The Alu-J Encoding Peptide/Alu-GPHA Expressed Exclusively in Early Chorionic Villus Tissues and Placenta and the Alu-J Encoding Peptide Is a New Early Pregnancy Biomarker GPHA has highly tissue-specific expression in the pituitary and placenta of mammals (Hearn et al. 1991 To distinguish the expression pattern of Alu-GPHA and GPHA in the chorionic villus tissues, we generated an additional rabbit polyclonal antiserum against the 15-mer peptide N-PPTKASQSARITDCP-C, which is the C-terminus of the Alu-J coding peptide, and has unique peptide sequences different from other Alu-J coding peptide sequences (sup plementary fig. S5 , Supplementary Material online). Western blot analysis also showed that this antibody can specifically detect Alu-GPHA, but not the GPHA protein (sup plementary fig. S5 , Supplementary Material online). Immunohistochemical analysis showed that Alu-GPHA is highly expressed in trophoblasts (Vctb: Villous cytotrophoblast; ST: Syncytiotrophoblast) of chorionic villus tissues during pregnancy, similar to GPHA (Guibourdenche et al. 2010; fig. 3B and supplementary fig. S6, Supplementary Material online) . We also checked Alu-GPHA expression in various stages (5 weeks, 7 weeks, 9 weeks, and 12 weeks) of chorionic villus tissues and as shown in supplementary figure S6, Supplementary Material online, Alu-GPHA maintains high expression during pregnancy. GPHA hetero-dimerizes with CGB to activate the LHR to function in hemochorial placentation during pregnancy (Fournier et al. 2015) ; so, we further check heterodimer expression by immunofluorescence analysis. As shown in figure 3C , immunofluorescence analysis of chorionic villus tissues showed that Alu-GPHA colocalized with CGB in trophoblasts of chorionic villus tissues (both Vctb and ST), similar to GPHA colocalizing with CGB in trophoblasts ( fig. 3C ; Guibourdenche et al. 2010 ). Taken together, our results suggest that the Alu-J encoding peptide is a new biomarker of early pregnancy and the Alu-GPHA may play an important role in the placentation of early embryonic development.
Alu-GPHA Hetero-Dimerizes with All Four BetaSubunits of Glycoprotein Hormones and the Heterodimers Stimulate Their Cognate Receptors with the Same Potency as the Normal GPHA Normal GPHA isoform hetero-dimerizes with all four betasubunits (CGB, LHB, FSHB, and TSHB) and the resultant heterodimers-HCG, LH, FSH, and TSH stimulates Gs signaling in cells expressing their corresponding receptors-LHR, LHR, FSHR, and TSHR, respectively (Fan and Hendrickson 2005) . To check whether the heterodimeric hormones formed by Alu-GPHA and all four beta-subunits stimulate Gs signaling via their corresponding receptors, we cotransfected of receptor-ligand expression plasmid and CRE-luciferase reporter for testing Gs signaling (Cheng et al. 2010) . As shown in figure 4A -D, Alu-HCG, Alu-LH, Alu-FSH, and Alu-TSH activate Gs signaling via their corresponding receptors with the same potency as HCG, LH, FSH, and TSH, respectively. Moreover, we generated the recombinant Alu-HCG and HCG proteins from their stably overexpressing HEK293 cell lines. To assess peptide bioactivity, we purified recombinant epitope-tagged Alu-HCG and HCG proteins by using two sequential affinity columns against FLAG and the poly-His epitope appended to the N-terminus of GPHA/Alu-GPHA and the C-terminus of CGB, respectively. Similarly, Alu-HCG and HCG also stimulated Gs signaling in cells expressing the LHR with the same potency ( fig. 4E ).
The glycoprotein hormone family members, including HCG, LH, FSH, and TSH, share a similar protein structure a common alpha-chain (GPHA), but they derive functional specificity from different beta-chains, which are highly selective to interact with corresponding receptors with very few cases of cross activity (Fan and Hendrickson 2005; Smits et al. 2003) . The C-termini of both GPHA and its beta subunit play an important role in heterodimer binding and activating its cognate receptor (Chen et al. 1992; Fan and Hendrickson 2005) . They share a similar receptor-ligand structure with the N-terminus of GPHA far away from the receptor-ligand binding/activating sites (Smits et al. 2003) . To investigate the structural relationship of the Alu-J encoding peptide and the receptor-ligand binding/activating sites, the threedimensional (3D) structure of the Alu-J encoding peptide was modeled using the CABS-fold server (Blaszczyk et al. 2013) , and the models of Alu-GPHA-FSHB heterodimer with FSHR were built using Pymol (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC) based on the structure of FSH in complex with the entire ectodomain of its receptor-FSHR (PDB ID: 4MQW). As shown in figure 4F , the Alu-J encoding peptide shows a classical alpha helix structure in the N-terminus of Alu-GPHA and far away from the binding/activating sites for FSH to FSHR, which is consistent with previous studies (Chen et al. 1992; Fan and Hendrickson 2005) . With luciferase experimental data (fig. 4A-E), our results show that the Alu-J coding peptide localizes the Nterminus of GPHA and does not directly interfere with glycoprotein hormones binding to their cognate receptors and activating their down-stream G protein signaling.
Alu-HCG Shows a Longer Serum Half-Life Due to the Alu-J Encoding Peptide
Circulating half-life in serum is important for the bioactivity of HCG, both in vivo and in vitro (Sugahara et al. 1995) . So, we detected the serum half-lives of Alu-HCG and HCG. With recombinant proteins, the pharmacokinetic profiles of Alu-HCG and HCG were determined via the administration of an intravenous (tail vein) injection. Interestingly, Alu-HCG was found to have an approximate 5-fold (82.3 min vs. 17.2 min) increased serum half-life, compared with HCG ( fig. 5A ).
Both the C-terminus of CGB and the C-terminus of GPHA play important roles in heterodimeric HCG binding to and activating their cognate receptor-LHR (Chen et al. 1992; Fan and Hendrickson 2005) . The Alu-J encoding peptide existing in the N-terminus of Alu-GPHA is far away from the binding/ activating site of its cognate receptor ( fig. 4F ; Chen et al. 1992; Fan and Hendrickson 2005) . The only difference between Alu-HCG and HCG is the additional N-terminus of Alu-GPHA consisting of the Alu-J encoding peptide. To confirm that a longer serum half-life of Alu-HCG is due to the Alu-J encoding Chen et al. . doi:10.1093/molbev/msx252 MBE peptide, we investigated the serum half-lives of the purified recombinant HCG proteins with different Alu-J encoding peptide mutants. Since the Alu-J encoding peptide was positively selected in the human and ape lineages ( fig. 2) , to further investigate how the Alu-J encoding peptide prolongs the serum half-life of Alu-GPHA, we also generated the ancestral Alu-HCG (the Alu-J encoding peptide of human was replaced by the ancestral Alu-J encoding peptide of squirrel monkey) and point mutants of Alu-HCG (both Ala mutant-K22A and reverse mutant-K22L in the Alu-J encoding peptide) for comparison. As shown in figure 5A , all mutants decreased the serum half-lives of their corresponding Evolution of Hemochorial Placentation in Primates . doi:10.1093/molbev/msx252 MBE heterodimeric peptides by varying degrees (Alu-HCG > K22A Alu-HCG > K22L Alu-HCG > ancestral Alu-HCG > HCG). Our result implied that after Alu-J early insertion, the ancestral Alu-J encoding peptide gained a new function for prolonging the half-life of the HCG protein, and after adaptive evolution and further functionalization, the Alu-J encoding peptide greatly prolonged the half-life of the HCG protein to satisfy some physiological requirement during primate evolution (Carter 2007; Cole 2009b) .
To investigate how the Alu-J encoding peptide prolongs the half-life of the entire HCG protein from its protein structure, we predicted the protein structures of the Alu-J encoding peptide and its relevant mutants by the CABS-fold server (Blaszczyk et al. 2013 ) and Pymol (The PyMOL Molecular   FIG. 4 . Gs signaling is stimulated by glycoprotein hormone heterodimers containing Alu-GPHA or GPHA. Glycoprotein hormone heterodimers-HCG, LH, FSH, and TSH containing Alu-GPHA or GPHA stimulate Gs signaling via (A) LHR, (B) LHR, (C) FSHR, or (D) TSHR. 293T cells permanently expressing individual human receptors were transfected with the CRE-luciferase reporter plasmid and increasing amounts of the Alu-GPHA or GPHA plasmid with its corresponding beta subunit plasmid-CGB, LHB, FSHB, and TSHB following the standard procedure of G-protein luciferase reporter assay. (E) Gs signaling of glycoprotein hormone heterodimers with purified Alu-HCG and HCG. 293T cells permanently expressing individual human receptors were transfected with the CRE-luciferase reporter and then treated with increasing doses of purified Alu-HCG and HCG. Function assay were repeated independently four times (n ¼ 4). (F) The three-dimensional (3D) structure of Alu-GPHA and FSHB interacting with its cognate receptor-FSHR. Alu-J encoding peptide, GPHA, FSHB, and FSHR are shown in red, blue, magenta, and grey, respectively. N-terminus and C-terminus of GPHA and FSHB are indicated by red dots. Chen et al. . doi:10.1093/molbev/msx252 MBE FIG. 5. Alu-HCG is a more effective polypeptide hormone. (A) Alu-HCG and its relevant mutants show a longer serum half-life than HCG in varying degrees. Half-life was studied by intravenous injection of 1ug of protein, in an injection volume of 500 ll of HCG and Alu-HCG protein; then, blood samples were taken in a time span of 90 min and incubated at room temperature for 90 min. Serum was isolated by centrifugation and analyzed for HCG content by ELISA. (B) Structural comparison of the three-dimensional structure of Alu-GPHA and its derivatives (ancestral Alu-GPHA and two point mutants Alu-GPHA). Alu-J encoding peptide, ancestral Alu-J encoding peptide, K22A Alu-J encoding peptide, K22L Alu-J encoding peptide, GPHA, and CGB are shown in red, yellow, cyan, green, blue, and orange, respectively. N-terminus and C-terminus of GPHA and CGB are indicated as red dots. (C) Structural comparison of the three-dimensional structure of Alu-J encoding peptide and its derivatives (ancestral Alu-GPHA and K22L Alu-J encoding peptide). Alu-J encoding peptide, ancestral Alu-J encoding peptide and K22L Alu-J encoding peptide are shown in red, yellow, and green, respectively. N-terminus of GPHA is indicated as red dot. The structural superposition of Alu-J encoding peptide and its derivatives is indicated, respectively. (D) In vivo ovulatory potency of Alu-HCG is greater than HCG. C57BL/6 female mice were i.p. (intraperitoneal) injected with 10 international units of PMSG on week 5. Forty-eight hours later, the hormone to be tested was i.p. (intraperitoneal) injected as 10 international units of HCG and Alu-HCG in sodium chloride. The following morning (12-14 h later) ovulation was scored by removing both oviducts and counting the number of eggs present. (E) Alu-HCG is significantly higher than HCG in increasing cell invasion. JEG-3 choriocarcinoma cell invasion was determined by invading through a basement membrane preparation with a standard procedure of BD BioCoat Matrigel Invasion Assay. Function assay were repeated independently five times (n ¼ 5). P value by Wilcoxon test and statistical significance was defined as a P value <0.05 (*) and P value <0.01(**). * or ** on the top of column was made concerning HCG or Alu-HCG versus control (0 nM); * or ** above line was made concerning Alu-HCG versus HCG. The actual P-values as belows: P ¼ 0.074 for 5 nM HCG versus control (0 nM); P ¼ 0.016 for 50 nM HCG versus control (0 nM); P ¼ 0.008 for 500 nM HCG versus control (0 nM); P ¼ 0.012 for 5 nM Alu-HCG versus control (0 nM); P ¼ 0.012 for 50 nM Alu-HCG versus control (0 nM); P ¼ 0.012 for 500 nM Alu-HCG versus control (0 nM); P ¼ 0.02 for 5 nM Alu-HCG versus 5 nM HCG; P ¼ 0.008 for 50 nM Alu-HCG versus 50 nM HCG; P ¼ 0.008 for 500 nM Alu-HCG versus 500 nM HCG. (F) Alu-HCG is significantly higher than HCG in increase Evolution of Hemochorial Placentation in Primates . doi:10.1093/molbev/msx252 MBE Graphics System, Version 1.8 Schrödinger, LLC). As shown in figure 5B , compared with the Alu-J encoding peptide, the K22A mutant of Alu-GPHA also show an alpha helix structure and only a slight difference from the human Alu-J encoding peptide. In contrast, both the ancestral Alu-J encoding peptide and reverse K22L mutant of Alu-GPHA show two alpha helix structures ligated with a coil, and shows large difference from the Alu-J encoding peptide ( fig. 5B and C) . The K residue in the 22nd position in the Alu-J encoding peptide was identified to be under positive selection (fig. 2B) . Interestingly, K22L reverse mutant of Alu-J encoding peptide show similar 3D structure with the ancestral Alu-J encoding peptide ( fig.  5C ). So, the structure comparison imply the adaptive evolution of Alu-J encoding peptide changed its secondary protein structure (two short alpha helixes to a long alpha helix) and the positive selected site-22nd K residue plays an important role in its protein structure ( fig. 5B and C) . With the results of the serum half-life experiment, the structure of the Alu-J encoding peptide imply that the Alu-J encoding peptide was selected to be a long alpha helix for further increasing the protein stability of HCG (Baboolal et al. 2009; Johnson et al. 2012) . Taken together, our results confirm that Alu-HCG has a longer serum half-life due to the Alu-J encoding peptide.
Alu-HCG Is a More Effective Hormone than HCG, Both In Vivo and In Vitro
Although the Alu-J coding peptide does not interfere in its heterodimeric hormones' activity for stimulating G protein signaling via their cognate receptors, it still prolongs Alu-HCG's serum half-life ( fig. 5A ). Serum half-life plays an important role in the function of HCG both in vivo and in vitro (Baenziger et al. 1992) . So, we further detected the function of Alu-HCG in vivo and in vitro. The administration of pregnant mare serum gonadotropin (PMSG) and HCG was used to induce follicular development and ovulation; HCG is a wellknown effective hormone for mammalian superovulation (Fowler and Edwards 1957; Mukumoto et al. 1995) . So, the in vivo activity was determined by testing its ovulatory potency in immature female rats pretreated with either Alu-HCG or HCG. As shown in figure 5D , the in vivo ovulatory potency of Alu-HCG is greater than HCG. The injection of 0.3 mg of HCG caused 3 out of 6 mice to ovulate and released 21 oocytes per rat, whereas the same amount of Alu-HCG caused 5 out of 6 mice to ovulate and released 62 oocytes per rat ($3-fold; fig. 5D ). Our results showed that Alu-HCG is more effective hormone than HCG in inducing superovulation in vivo.
Trophoblast invasion is necessary for successful pregnancy and, placental implantation and invasion characteristics in primates are related to the invasion activity of CG (Carter 2007; Cole 2010 Cole , 2009b . A trophoblast invasion model, human choriocarcinoma cell line (JEG-3) was used for a trophoblast invasion activity test (Lee et al. 2013; Zygmunt et al. 1998) . Consistent with previously published results (Lee et al. 2013; Zygmunt et al. 1998) , the treatment of JEG-3 cells with different concentrations of HCG (5-500 nM) resulted in a significant and dose dependent increase in cell invasion ( fig.  5E ). In contrast, Alu-HCG showed a significantly higher (2-fold more) increase in cell invasion than HCG ( fig. 5E ). We further checked the cell migration activity between Alu-HCG and HCG. Similarly, Alu-HCG showed a significantly higher (nearly 2-fold in 50 nM and 500 nM) increase in cell migration than HCG ( fig. 5F ). Our results identified Alu-HCG as a more effective polypeptide hormone than HCG in vitro. Taken together, Alu-HCG is more effective than HCG both in vivo and in vitro.
Both Alu-J Encoding Peptide and Ancestral Alu-J Encoding Peptide Enhance the Bioactivity of CG/HCG Protein In Vitro
Alu-HCG shows better bioactivity with a longer serum halflife and as a more effective hormone in cell invasion/migration in vitro due to the Alu-J encoding peptide ( fig. 5 ). To further confirm the better bioactivity is enhanced by the Nterminal Alu-J encoding peptide, we compared the bioactivity between the Alu-CG and the CG with purified recombinant Alu-CG and CG proteins of philippine tarsier (S. boliviensis). To confirm Alu-CG also has better hormone activity, we also investigated the invasion/migration activity between Alu-CG and CG with trophoblast invasion/migration activity test. As shown in figure 6A and B, the treatment of JEG-3 cells with Alu-CG (both 50 nM and 500 nM) or CG (both 50 nM and 500 nM) resulted in a significant increase in cell invasion and cell migration. Also, Alu-CG showed a significantly higher (both 50 nM and 500 nM) increase in cell invasion than CG and showed a significantly higher (500 nM) increase cell migration than CG, respectively ( fig. 6A and B) .
When Alu-J encoding peptide was positively selected for functionalization in human and ape lineages, ancestral Alu-J encoding peptide was also exonized in new world monkey and old world monkey lineages (figs. 1 and 2). Since ancestral Alu-HCG has a longer half-life than HCG ( fig. 5A) , ancestral Alu-HCG may has better hormone activity. So, we also checked the invasion/migration activity between ancestral Alu-HCG and HCG with trophoblast invasion/migration FIG. 5 Continued cell migration. JEG-3 choriocarcinoma cell migration was determined by the 96-well CytoSelect cell migration assay with a standard procedure. Function assay were repeated independently five times (n ¼ 5). P value by Wilcoxon test and statistical significance was defined as a P value <0.05 (*) and P value <0.01(**). * or ** on the top of column was made concerning HCG or Alu-HCG versus control (0 nM); * or ** above line was made concerning Alu-HCG versus HCG. The actual P-values as belows: P ¼ 0.25 for 5 nM HCG versus control (0 nM); P ¼ 0.027 for 50 nM HCG versus control (0 nM); P ¼ 0.012 for 500 nM HCG versus control (0 nM); P ¼ 0.008 for 5 nM Alu-HCG versus control (0 nM); P ¼ 0.008 for 50 nM Alu-HCG versus control (0 nM); P ¼ 0.008 for 500 nM Alu-HCG versus control (0 nM); P ¼ 0.68 for 5 nM Alu-HCG versus 5 nM HCG; P ¼ 0.016 for 50 nM Alu-HCG versus 50 nM HCG; P ¼ 0.008 for 500 nM Alu-HCG versus 500 nM HCG.
Chen et al. . doi:10.1093/molbev/msx252 MBE activity test. Similarly with comparison between Alu-HCG and HCG, ancestral Alu-HCG showed a significantly higher (both 50 nM and 500 nM) increase in cell invasion and cell migration than HCG ( fig. 6C and D) . Our results showed ancestral Alu-J encoding peptide also enhances the bioactivity of HCG protein. Taken together, our results show both ancestral Alu-J encoding peptide and Alu-J encoding peptide enhance the bioactivity of CG/HCG protein.
FIG. 6.
Both Alu-J encoding peptide and ancestral Alu-J encoding peptide enhance the bioactivity of CG/HCG protein in vitro. (A) Alu-CG is significantly higher than CG in increasing cell invasion. JEG-3 choriocarcinoma cell invasion was determined by invading through a basement membrane preparation with a standard procedure of BD BioCoat Matrigel Invasion Assay. Function assay were repeated independently five times (n ¼ 5). P value by Wilcoxon test and statistical significance was defined as a P value <0.05 (*) and P value <0.01 (**).The actual P-values as belows: P ¼ 0.008 for 50 nM Alu-CG versus control (0 nM); P ¼ 0.008 for 500 nM Alu-CG versus control (0 nM); P ¼ 0.036 for 50 nM CG versus control (0 nM); P ¼ 0.012 for 500 nM CG versus control (0 nM); P ¼ 0.008 for 50 nM Alu-CG versus 50 nM CG; P ¼ 0.008 for 500 nM Alu-CG versus 500 nM CG. (B) Alu-CG is significantly higher than CG in increasing cell migration. JEG-3 choriocarcinoma cell migration was determined by the 96-well CytoSelect cell migration assay with a standard procedure. Function assay were repeated independently five times (n ¼ 5). P value by Wilcoxon test and statistical significance was defined as a P value <0.05 (*) and P value <0.01(**). The actual P-values as belows: P ¼ 0.008 for 50 nM Alu-CG versus control (0 nM); P ¼ 0.008 for 500 nM Alu-CG versus control (0 nM); P ¼ 0.008 for 50 nM CG versus control (0 nM); P ¼ 0.008 for 500 nM CG versus control (0 nM); P ¼ 0.095 for 50 nM Alu-CG versus 50 nM CG; P ¼ 0.03 for 500 nM Alu-CG versus 500 nM CG. (C) Ancestral Alu-HCG is significantly higher than HCG in increasing cell invasion. Function assay were repeated independently five times (n ¼ 5). P value by Wilcoxon test and statistical significance was defined as a P value <0.05 (*) and P value <0.01(**). The actual P-values as belows: P ¼ 0.012 for 5 nM Ancestral Alu-HCG versus control (0 nM); P ¼ 0.012 for 50 nM Ancestral Alu-HCG versus control (0 nM); P ¼ 0.012 for 500 nM Ancestral Alu-HCG versus control (0 nM); P ¼ 0.03 for 5 nM HCG versus control (0 nM); P ¼ 0.008 for 50 nM HCG versus control (0 nM); P ¼ 0.008 for 500 nM HCG versus control (0 nM); P ¼ 0.6 for 5 nM Ancestral Alu-HCG versus 5 nM HCG; P ¼ 0.032 for 50 nM Ancestral Alu-HCG versus 50 nM HCG; P ¼ 0.008 for 500 nM Ancestral Alu-HCG versus 500 nM HCG. (D) Ancestral Alu-HCG is significantly higher than HCG in increase cell migration. Function assay were repeated independently five times (n ¼ 5). P value by Wilcoxon test and statistical significance was defined as a P value <0.05 (*) and P value <0.01(**). The actual P-values as belows: P ¼ 0.016 for 5 nM Ancestral Alu-HCG versus control (0 nM); P ¼ 0.008 for 50 nM Ancestral Alu-HCG versus control (0 nM); P ¼ 0.008 for 500 nM Ancestral Alu-HCG versus control (0 nM); P ¼ 0.047 for 5 nM HCG versus control (0 nM); P ¼ 0.008 for 50 nM HCG versus control (0 nM); P ¼ 0.008 for 500 nM HCG versus control (0 nM); P ¼ 0.67 for 5 nM Ancestral Alu-HCG versus 5 nM HCG; P ¼ 0.016 for 50 nM Ancestral Alu-HCG versus 50 nM HCG; P ¼ 0.008 for 500 nM Ancestral Alu-HCG versus 500 nM HCG. Approximately half of the human genome is derived from transposable elements and, among these transposable elements, particularly Alu elements, can become exonized in a tissue-or tumor-specific manner (Keren et al. 2010) . Alu elements are unique primate-specific retrotransposons that account for $10% of the human genome. The 300 base-pair consensus Alu sequence contains motifs that resemble 5 0 and 3 0 potential splice sites and random mutations can turn these motifs into functional splice sites (Athanasiadis et al. 2004; Lev-Maor et al. 2003) . In particularly, Alu-derived internal exons are usually alternatively spliced, thus allowing the original isoform to coexist with the newly formed variant and the possibility to evolve new functions (Lev-Maor et al. 2003) . So, the exonization of Alu elements is a major mechanism for de novo exon creation in primate and human genomes (Lev-Maor et al. 2003) .
Although the regulatory function of exonized Alu elements has been investigated in many studies (Chen et al. 2008; Shen et al. 2011; Vansant and Reynolds 1995) , the functionalization of Alu elements in protein coding regions remains unknown. Even, in the 5 0 UTR of the GPHA gene, an Alu exon insertion resulted in the formation of a potential regulatory element, but no significant effect was detected in the expression and function of GPHA (Scofield et al. 2000) . In this study, we report that an Alu-J element inserted between the exon 1 encoding signal peptide of GPHA and the exon 2 encoding mature GPHA peptide, and subsequent GC to GT substitution, created a new and alternative splicing Alu-J exon encoding 31 residues (Alu-J encoding peptide) constituting the additional N-terminus of GPHA in anthropoid primates $35 Ma (figs. 1 and 7; Schrago and Russo 2003; Steiper and Young 2006) . In our study, Alu-J derived internal exon was alternatively spliced, allowing the original isoform (GPHA) to coexist with the newly formed variant (Alu-GPHA) to be selected to gain of a new function-prolonging the serum half-life (figs. 1, 3, and 5; Lev-Maor et al. 2003) .
With a generated polyclonal antibody, we found that the Alu-J encoding peptide is expressed exclusively in earlier chorionic villus tissues and placenta, and is a new biomarker of early pregnancy (fig. 3) . The Alu-J encoding peptide/Alu-GPHA shows colocalization with CGB and cell signaling studies suggest that its heterodimer is the functional polypeptide hormone ( figs. 3 and 4) . Moreover, with a prolonged serum half-life, Alu-HCG is a more effective hormone in superovulation in vivo than HCG and Alu-HCG/Alu-CG shows better bioactivity in cell invasion/migration in vitro than HCG/CG (figs. 5 and 6). Taken together, to the best of our knowledge, Alu-GHPA is the first example of the functionalization of the Alu element in protein coding regions and our results imply that the Alu-J element, or other Alu subfamilies, can play multiple-roles in the protein coding regions after their exonization.
The Exonization and Functionalization of the Alu-J Exon in GPHA Gene Represent a Novel Mechanism to the Evolution of Hemochorial Placentation in Primates
According to the evolution of primate hemochorial placentation, human hemochorial placentation evolved from the more primitive hemochorial placentation seen in advanced and early simian primates ( fig. 7; Luckett 1974) . As shown in figure 7 , in the prosimian primates, epitheliochorial placentation was sufficient and this process involves the placenta loosely attaching to the wall of the endometrial stroma with no invasion (Carter 2007; Cole 2010 Cole , 2009b Luckett 1974) . CG plays an important role to drive hemochorial placentation and it was well known that the evolution of CGB gene provides good explanation to the evolution of hemochorial placentation in primates ( fig. 7 ; Cole 2009a Cole , 2009b Gundling and Wildman 2015; Maston and Ruvolo 2002) .
Hemochorial placentation started in the early simian primates and in around same time, LHB was duplicated to create a new copy (ancestral CGB) in anthropoids ( fig. 7 ; Maston and Ruvolo 2002) . Subsequently, in the duplicate copy (ancestral CGB), a deletion mutant occurred on the termination codon and transcription continued though (Maston and Ruvolo 2002) . Finally, the CGB gained an additional and longer C-terminus (24 residues), which has the glycosylation sites to prolong the half-life of CG compared with the original hormone-LH, and the glycosylated CG and regular CG were known to start hemochorial placentation and placental invasion in anthropoids (anthropoids also known as simians; fig. 7 ; Cole 2009a Cole , 2009b . Moreover, in the early simian primates, placenta invading through the thickness of the decidua only was linked with 2 O-and 1 N-glycosylated CGB (short circulating half-life of CG-70 min; fig. 7 ). In contrast to the advances simian primates and human, the placenta invasion was permitted through the decidua to one-tenth and to one-third the thickness of the myometrium, which were linked with that the CGB underwent multiple point mutants to create 3 O-and 1 N-glycosylated CG (longer circulating half-life of CG-240 min) in the advances simian primates and 4 O-and 2 N-glycosylated CG (longest circulating half-life of CG-2100 min) in the human, respectively ( fig. 7; Cole 2009a Cole , 2009b Cole , 2010 .
So, It has been well known that the evolution of CG beta unit-CGB gene which forms heterodimeric CG (CG) with GPHA provides good explanation to the evolution of hemochorial placentation in primates (fig. 7; Carter 2007; Cole 2009a Cole , 2009b . However, in this evolution of hemochorial placentation in primates, the changes of the CG alpha unit-GPHA were omitted. Similar to the CGB, in this study and as shown in figures 1 and 7, Alu-J exon insertion gained an additional and longer N-terminus of GPHA to create an alternative splicing variant (Alu-GPHA), and its heterodimer (Alu-HCG) also shows a longer serum half-life compared with normal HCG, even ancestral Alu-HCG shows a longer serum half-life compared with normal HCG (fig. 5A ). Finally, a natural and more effective polypeptide hormone (Alu-HCG/AluChen et al. . doi:10.1093/molbev/msx252 MBE CG) for early pregnancy resulted in human and ape lineages ( fig. 7) .
As shown in figure 7, after Alu-J insertion in the early simian primate (OWM/NWM-old world monkey/new world monkey), the ancestral Alu-J encoding peptide gained a new function for prolonging the HCG/CG circulating half-life and increasing in cell invasion/migration ability (figs. 5A, 6C and D), and after adaptive evolution and further functionalization in the advanced simian primate and human, the Alu-J encoding peptide furtherly prolonged the HCG/CG circulating halflife and increasing in cell invasion/migration ability ( fig. 5A , E and F). Alu-derived internal exons are usually alternatively spliced, thus allowing the original isoform to coexist with the newly formed variant and the possibility to evolve new functions (Lev-Maor et al. 2003) . So, although Alu-GPHA only represents one GPHA isoform from alternative splicing, we speculate that the ancestral Alu-J encoding peptide and Alu-J encoding peptide, at least partially, contributes to the improved placental implantation and invasion characteristics from prosimian primates to early simian primates and from early simian primates to advances simian primates and human, respectively ( fig. 7) . So, following CGB origination/mutation and Alu-J exonization/positive selection, CG and Alu-CG (both regular and glycosylated forms), for example, HCG and Alu-HCG, became more and more effective hormones contributing to improve placental implantation and invasion characteristics from prosimian primates to early simian primates to advances simian primates and human (fig. 7; Cole 2009a Cole , 2009b . So, the exonization and functionalization of the Alu-J exon in GPHA was likely an important step for the evolution of hemochorial placentation in primates. Also, we speculate that the Alu-J encoding peptide was originated and positively selected to gain the new function: to prolong the longer half-life and acquire better invasion activity of HCG/ CG to satisfy the improving placental implantation and invasion characteristics acquirement during pregnancy in primate evolution (fig. 7; Carter 2007; Cole 2009b) . Taken together, the exonization and functionalization of the Alu-J exon in GPHA gene represent a novel mechanism to the evolution of hemochorial placentation in primates.
The Long Alpha Helix Structure, Encoded by Alu-J Exon, as a Natural N-Terminal Modification Tool for Peptide Drug to Improve the Drug Effectiveness
The N-terminus of Alu-GPHA is far away from the binding and activating sites for HCG to its cognate receptor-LHR (Chen et al. 1992; Fan and Hendrickson 2005) , and heterodimers formed with Alu-GPHA show no difference in acting on the G protein pathway via their cognate receptors with heterodimers formed with GPHA ( fig. 4) . However, the Alu-J encoding peptide largely prolongs the hormone serum halflife ($5-fold) of HCG ( fig. 5A) . Additionally, the potency of prolonging the hormone serum half-life of the Alu-J encoding peptide is greater than two point mutants and the ancestral Alu-J encoding peptide ( fig. 5A ). On the basis of 3D-structure prediction, the Alu-J encoding peptide was found to be a long alpha helix structure in the N-terminus of Alu-GPHA ( fig. 5B and C). In contrast, the ancestral Alu-J encoding peptide and reverse mutant-K22L of the Alu-J encoding peptide show two alpha helix structures ligated with a coil, with large difference from the human Alu-J encoding peptide ( fig. 5B and   FIG. 7 . Diagram of the evolution of the Alu-GPHA, CGB, and hemochorial placentation in primates. According to our study, the insertion, exonization and positive selection of Alu-J exon in primate evolution are indicated. According to previous studies (Cole 2009b) , the origination and glycosylation of CGB are indicated and linked with implantation characteristics, depth of invasion and CG circulation half-life. Taisius/otolemur belong to prosimian primate, OWM/NWM (old world monkey/new world monkey) belong to early simian primate, and apes belong to advanced simian primate.
Evolution of Hemochorial Placentation in Primates . doi:10.1093/molbev/msx252 MBE C). So, we speculate that the human Alu-J peptide largely increases the stability of the entire HCG protein more than the ancestral Alu-J peptide due to the long alpha helix structure ( fig. 5B and C ; Baboolal et al. 2009; Johnson et al. 2012) . Further studies can investigate how a long alpha helix structure increases the whole protein stability.
Circulating half-life in serum is important for peptide hormone or peptide drug bioactivity both in vivo and in vitro (Sugahara et al. 1995) . HCG is a well-known effective hormone for mammalian superovulation (Fowler and Edwards 1957; Mukumoto et al. 1995) . Our results identified that the Alu-HCG shows a longer serum half-life compared with normal HCG ( fig. 5A ) and Alu-HCG can be considered as a more effective tool for mammalian superovulation ( fig. 5D ). Additionally, we believe that chimeric Alu-LH, Alu-FSH, and Alu-TSH also have longer serum half-lives and will be more effective hormones comparing to their normal heterodimers. Similarly, in peptide drugs, short half-life times are, in most cases, not effective in delivering sufficient peptide drug amounts to the target tissue, and modification of the Nand C-termini prolongs the peptide half-lives to evaluate the effectiveness of drug modifications (Werle and Bernkop-Schnurch 2006) . Taken together, our results indicated that the Alu-J encoding peptide can be used as a natural N-terminal modification for peptide drug to improve the drug effectiveness.
Materials and Methods

Sample and Gene Cloning
Chorionic villus tissues, term placenta and blood samples were obtained from the Reproductive Medical Center of the Nanjing Jinling Hospital and the Collaborative Innovation Platform for Reproductive Biology and Technology, Nanjing University School of Medicine. GPHA, Alu-GPHA, CGB, LHB, FSHB, TSHB, LHR, FSHR, and TSHR cDNA were cloned and subsequently subcloned into a pcDNA3.1 vector for expression in HEK293 cell line; CREluciferase reporter plasmids, as well as the pSV-bgalactosidase control vectors, were purchased from Promega.
Expression and Purification of Human HCG/CG and Alu-HCG/Alu-CG The expression vector pcDNA3.1 containing the human or philippine tarsier GPHA/Alu-GPHA/Alu-GPHA relevant mutants with neomycin selection antibiotic or CGB with zeocin selection antibiotic was transfected into mammalian 293T cells using Lipofectamine 2000 (Invitrogen), and transfected cells were selected using neomycin-and zeocincontaining medium. Selected cells were allowed to reach confluence and then cultured for one week in a serum-free medium (DMEM/Ham's F12 medium containing 100 lg/ml penicillin, 100 lg/ml streptomycin, and 2 mM L-glutamate). After filtration, the conditioned media were concentrated. To facilitate purification, human GPHA/Alu-GPHA or CGB constructs were tagged with His-6-or FLAG-tagged epitopes, respectively, at the N-terminus by replacing the endogenous signal peptide with a prolactin signal peptide and the epitope tags. To generate recombinant HCG/Alu-HCG, cells coexpressing human GPHA/Alu-GPHA and CGB were clonally selected and confirmed based on tagged epitopes. Conditioned media were further purified by using metal chelating Sepharose (Amersham Pharmacia) against His-6-CGB followed by antiFLAG M1 affinity gel (Sigma) against FLAG-GPHA/Alu-GPHA. Protein purity and biochemical characteristics were analyzed after electrophoresis using a 12% SDSpolyacrylamide gel. The purity of HCG and Alu-HCG was confirmed using SDS/PAGE followed by Coomassie blue staining.
Quantitative RT-PCR Human normal cDNA array for 48 tissues was purchased from OriGene Technologies as the template. Total RNA was extracted from chorionic villus tissues (5-12 weeks) and term placenta sample, and 500 ng of total RNA was reverse-transcribed to cDNAs using the following master mix: 6 ml of RNase-free water, 2 ml of 5Â PrimeScript RT Master Mix (Takara, China), and total RNA (500 ng). A master mix of the following reaction components was prepared: 6.8 ml of water, 0.4 ml of forward primer (10 mM), 0.4 ml reverse primer (10 mM), 10 ml SYBR Premix Ex Taq (TliRnaseH Plus) (Takara, China), and 0.4 ml of ROX Reference Dye I before adding 2 ml of PCR templates. The following real-time PCR protocol was used: denaturation for 30 s at 95 C, 40 cycles of a three segmented amplification and quantification program (denaturation for 30 s at 95 C, annealing for 5 s at the primer specific temperature, and elongation for 30 s at 60 C), and a melting step by slow heating from 60 to 99 C. Expression of the transcripts was normalized to GAPDH levels. Data were analyzed using Graphpad Prism 5.0.
Phylogenetic Analysis and Selection Analysis of the Alu-J Encoding Peptide
The Alu-J exon was translated to amino acid sequences from eleven primates and aligned with ClustalX version 1.8 using default settings. Phylogenetic trees were constructed using Neighbor-Joining (NJ) with 1,000 bootstrap replicates in MEGA version 6. We used the branch-site model of PAML version 4.4 to test for positive selections on interested branches and identify the codons under selection. The eleven primate species are as follows: Homo: Homo sapiens; Pan: Pan troglodytes; Gorilla: Gorilla gorilla; Pongo: Pongo abelii; Nomascus: Nomascus leucogenys; Macaca: Macaca mulatta; Papio: Papio Anubis; Mandrillus: Mandrillus leucophaeus; Colobus: Colobus angolensis palliates; Saimiri: S. boliviensis; Callithrix: Callithrix jacchus.
Luciferase Assays
HEK293T cells were seeded in 24-well plates and were cotransfected with the CRE luciferase reporter plasmid (50 ng), the pSV-b-Gal plasmid (10 ng), the LHR or FSHR or TSHR receptor (30 ng), and GPHA/Alu-GPHA (0-10 ng) with its heterodimeric beta subunit plasmid (0-10 ng). After 24 h, cells were treated in serum-free media for another 12 h. Luciferase activities were determined using luciferase assay kits (Beyotime, China) and normalized to b-galactosidase Chen et al. . doi:10.1093/molbev/msx252 MBE activity. All experiments were performed at least three times in triplicates. Data were analyzed using Graphpad Prism 5.0.
Immunocytochemical Staining
Chorionic villus tissues were fixed for 12 h in 4% PFA, dehydrated in 30% sugar overnight, and subsequently embedded in Tissure-Tek O.C.T. compound. For immunocytochemical staining, 7-lm frozen sections were fixed for 30 min in ice acetone, washed three times with PBS, followed by three times with 0.2% Triton, and immunostained with HCG primary antibodies (1:200 antiGPHA antibody ab196505, Abcam; 1:200 antiCGB antibody ab9582, Abcam; and 1:200 anti-Alu [Biowold, China] ). Sections were counterstained with hematoxylin, and analyzed by light microscopy. Photomicrographic images were captured using a Nikon microscope and a Nikon DS-Ri 2 monochrome microscope camera.
Immunofluorescence
For the colocalization of GPHA/Alu-GPHA and CGB, chorionic villus tissues were fixed, sequentially stained with mouse antiCGB antibody ab9582 (Abcam) and rabbit antiCGA antibody ab196505 (Abcam)/antiAlu (Biowold, China), and then stained with goat anti mouse IgG secondary antibody Alexa Fluor 488 conjugate and goat anti rabbit IgG(H þ L) secondary antibody Alexa Fluor 594 conjugate. Nuclei were stained with 4 0 , 6-diamidino-2-phenylindole (DAPI). Immunofluorescence was examined under a Nikon DS-Ri 2 monochrome microscope camera.
Pharmacokinetic Experiments
Female Sprague Dawley rats were obtained from the breeder at a weight of 200-220 g for the pharmacokinetic experiments. They were housed in a temperature-controlled room at 23 C, with a 12 h light period from 0600 h to 1800 h and free access to food and water. All experiments were conducted in accordance with accepted standards of humane animal care. Half-life was studied by i.v. (intravenous) injection of 1 mg protein, in an injection volume of 500 ll. In each experiment, three rats in the reference group received HCG, and three other rats received Alu-HCG. Blood samples were taken in a time span over 200 min and incubated at room temperature for 90 min. Serum was isolated by centrifugation (5,000 rpm for 30 min) and stored at -80 C. Serum samples were analyzed for HCG content by ELISA (ab108638-Chorionic Gonadotropin beta Human ELISA Kit, Abcam). All experiments were performed at least three times in triplicates. Data were analyzed using Graphpad Prism 5.0. Superovulation C57BL/6 female mice were obtained from the breeder at an age of 4 weeks. All animals received an i.p. (intraperitoneal) injection of 10 international units of PMSG (NINGBO, China) at 5 weeks of age. Forty-eight hours later, the hormone (Alu-HCG or HCG) to be tested was given by i.p. (intraperitoneal) injection of 10 international units in sodium chloride. The first group of animals received the vehicle; the second group received Alu-HCG 10 IU; and the third group received HCG 10 IU. The following morning (12-14 h later) ovulation was scored by removing both oviducts and counting the number of eggs present.
Cell Invasion and Migration
To test cell invasion, JEG-3 choriocarcinoma cell (CellBank: TCHu195) were cultured in Minimum Essential Medium (Life: 41500034) supplemented with 10% fetal bovine serum (FBS), Sodium Pyruvate 0.11 g/l, 50 U/ml of penicillin and 50 mg/ml of streptomycin. For the invasion and migration assays, FBS was not added to the medium. To analyze trophoblast invasion, 5 Â 10 5 JEG-3 cells were treated with different HCG and Alu-HCG preparations at concentrations of 5-500 nM for 24 h while the cells were allowed to invade through a basement membrane preparation (BD BioCoat Matrigel Invasion Assay, BD Biosciences, Bedford, MA). In the upper invasion chamber containing cells, culture medium without FBS was used, whereas the lower chamber contained culture medium with 10% FBS. The invaded cells on the PET membrane were stained with crystal violet for visualization by light microscopy. Invasion was quantified by measuring the absorbance of crystal violet at 595 nm after extracting the dye on the membrane with 10% acetic acid; Cell migration was determined by the 96-well CytoSelect cell migration assay (Cell Biolabs, Inc., San Diego, CA). The assay utilizes a polycarbonate membrane plate (8 lm pore size) as a barrier to discriminate migratory cells from nonmigratory ones. JEG-3 cells (0.5 Â10
5
) were treated with 0-500 nM of different hCG forms in serum free medium in the upper migration chamber for 24 h. The lower chamber contained cell culture medium with 10% FBS. Cells that had migrated to the bottom surface of the membrane were dislodged by the cell detachment solution provided with the kit, lysed and quantified with CyQuant GR Dye using a fluorescence plate reader with excitation at 485 nm and emission at 530 nm. Results were expressed as percentage of fluorescence intensity relative to the control without treatment.
Modeling Structure
The three-dimensional Alu-J encoding peptide and its relevant structures were modeled using CABS-fold server (Blaszczyk et al. 2013 ). The models of Alu-GPHA/Alu-HCG and its relevant compounds were built using Pymol (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC), and energy minimization of the structure was done using the UCSF Chimera package minimized by the Chimera 1.eleven.2 (Pettersen et al. 2004 ), based on the crystal structure of human chorionic gonadotropin (HCG) at 2.6 Å resolution from mad analysis of the selenomethionyl protein (PDB ID: 1HCN), whereas the molecular graphic of Alu-FSH in complex with the entire ectodomain of its receptor-FSHR (P31) (PDB ID: 4MQW) and results of de novo modeling was performed using the CABS-fold server (Blaszczyk et al. 2013) . Energy minimization of the structure was done using the UCSF Chimera package (Pettersen et al. 2004 ), based on the crystal structure of HCG at 2.6 Å resolution from mad analysis of the selenomethionyl protein (PDB ID: 1HCN) and structure of FSH in complex with the entire ectodomain of its Evolution of Hemochorial Placentation in Primates . doi:10.1093/molbev/msx252 MBE receptor-FSHR (PDB ID: 4MQW). The refined models were estimated by QMEAN server (Benkert et al. 2009 ), and QMEAN scores were over 0.5 (Benkert et al. 2008) .
Statistics
Experiments for in vitro function assay including luciferase reporter assay and immunoblotting were repeated independently at least 3 times. Every animal group for in vivo experiments included at least five animals for tested independently. Data were analyzed using Graphpad Prism 5.0. Differences between two groups were compared using Wilcoxon test. Data are expressed as mean 6 SEM. Statistical significance was defined as a P value <0.05 (*) or P value <0.01(**).
Supplementary Material
Supplementary data are available at Molecular Biology and Evolution online.
